반응식
[O:1]1[C:5]2[CH:6]=[CH:7][C:8]([CH2:10][N:11]3[CH2:16][CH2:15][NH:14][CH2:13][CH2:12]3)=[CH:9][C:4]=2[O:3][CH2:2]1.C1([O:23][C:24](=O)[NH:25][C:26]2[S:27][CH:28]=[CH:29][N:30]=2)C=CC=CC=1>>[S:27]1[CH:28]=[CH:29][N:30]=[C:26]1[NH:25][C:24]([N:14]1[CH2:13][CH2:12][N:11]([CH2:10][C:8]2[CH:7]=[CH:6][C:5]3[O:1][CH2:2][O:3][C:4]=3[CH:9]=2)[CH2:16][CH2:15]1)=[O:23]참가 물질
3
실험 절차
The title compound was prepared from 1-benzo[1,3]dioxol-5-ylmethyl-piperazine and thiazol-2-yl-carbamic acid phenyl ester in analogy with Example 142. 1H NMR (400 MHz, CDCl3): 7.30 (d, J=4.0 Hz, 1H), 6.89 (s, 1H), 6.85 (d, J=3.8 Hz, 1H), 6.77 (s, 2H), 5.97 (s, 1H), 5.96 (s, 2H), 3.62 (bs, 4H), 3.53 (s, 2H), 2.54 (bs, 4H).
출처 및 근거
- ORD 기록
- ord-6b8c0d1b986947319798dfc2aaca0a0e
- 출처 데이터셋
- uspto-grants-2013_09
- 특허 번호
- US08530476B2
연결된 노트
불러오는 중…